Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$993,536
+$698,996 QoQ
Shares Held
12,586
+249.7% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $12,747,319,362 across 44 Diagnostics & Research names. BLLN ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,863,528 | $5,339,749,905 | |
| 2 | DHR |
Danaher Corp /De/
|
11,209,240 | $2,125,271,895 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,315,954 | $739,421,381 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
488,081 | $615,567,750 | |
| 5 | A |
Agilent Technologies, Inc.
|
4,949,129 | $564,101,713 | |
| 6 | DGX |
Quest Diagnostics Inc
|
2,479,720 | $485,975,515 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,609,867 | $445,086,710 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,498,027 | $399,688,576 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $993,536 | 12,586 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $294,540 | 3,599 | Shares | Defined | 2026-05-27 | |
| No filing history on record for this holder in this stock. | ||||||